Browsed by
Month: April 2022

NIH Career Symposium

NIH Career Symposium

Open to any postdoctoral fellow, clinical fellow, or PhD-level graduate student, this virtual event will run from May 11-13. The symposium will highlight the diversity of career choices available to the next generation of biomedical researchers. Registration opens April 15. ...  Read more

AstraZeneca R&D Postdoctoral Challenge

AstraZeneca R&D Postdoctoral Challenge

Outstanding final year MD and/or PhD students, or postdoctoral researchers who have received their degree within five years, are invited to propose innovative ideas to accelerate drug discovery and development. Shortlisted applicants will have the opportunity to pitch their research proposals to a world-leading judging panel, with the potential to be awarded a fully funded postdoctoral position at AstraZeneca. ...  Read more

NIST SBIR Funding for Coronavirus Programs

NIST SBIR Funding for Coronavirus Programs

NIST has released a new Small Business Innovation Research (SBIR) funding opportunity funded through the American Rescue Plan. Awards will support the purposes of the American Rescue Plan for “research, development, and testbeds to prevent, prepare for, and respond to coronavirus.” The fast-track competition requires both Phase I and Phase II applications to be submitted together. ...  Read more

Grants Available through the Maryland Supply Chain Resiliency Program

Grants Available through the Maryland Supply Chain Resiliency Program

The Maryland Supply Chain Resiliency Program assists Maryland manufacturers that have been adversely affected by the COVID-19 pandemic, with impacts on operations, supply chain, and/or sales. The program includes a business assessment and review of the company’s business practices to better understand the impacts on the business and the opportunities to help the company overcome them. ...  Read more

Unanet CRM Receives 2022 CUSTOMER Magazine Product of the Year Award

Unanet CRM Receives 2022 CUSTOMER Magazine Product of the Year Award

This is the second time Unanet’s CRM software has been honored by the experts at TMC and CUSTOMER Magazine.

Published on April 5, 2022

Dulles, VA, April 4, 2022 – Unanet, the leading the leading provider of project-based ERP and CRM for the government contractor (GovCon), architecture, engineering and construction (AEC) industries, today announced that that TMC, a global, integrated media company, has named Unanet CRM by Cosential as a 2022 CUSTOMER Product of the Year Award winner. ...  Read more

Astek Diagnostics received funding and support from TEDCO’s Maryland Innovation Initiative and SBIR/STTR Proposal Lab

Astek Diagnostics received funding and support from TEDCO’s Maryland Innovation Initiative and SBIR/STTR Proposal Lab

COLUMBIA, Md. (March 18, 2022)TEDCO, Maryland’s economic engine for technology companies, announced today its Builder Fund invested $100,000 in Astek Diagnostics, a medical device start-up based in Maryland. TEDCO’s Builder Fund invests in and provides executive support to Maryland-based technology companies run by entrepreneurs who demonstrate economic disadvantage. ...  Read more

Ellume Celebrates Grand Opening of First American Facility in Frederick, MD

Ellume Celebrates Grand Opening of First American Facility in Frederick, MD

Governor Larry Hogan joined dozens of attendees at Ellume‘s grand opening in Frederick on March 31 to welcome the diagnostics manufacturer to Frederick County. Ellume’s 215,000-square-foot production facility on Executive Way has been up and running since February 2022, only ten months after the company signed a lease with Matan Properties...  Read more

MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities

MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies

Brings biopharmaceutical industry closer to digitally-enabled manufacturing facility of the future

MAST® Platform provides real-time process information; cuts process development time by half, improving efficiency and lowering costs

Burlington, MA, April 5, 2022 – MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced the acquisition of MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. The MAST® platform was developed in Bend, Oregon. The financial details of the deal were not disclosed. ...  Read more

Prestigious Annual Pediatric Medical Device Pitch Competition Returns with $150K in FDA Awards and Accelerator Program

Prestigious Annual Pediatric Medical Device Pitch Competition Returns with $150K in FDA Awards and Accelerator Program

Applications open now through April 22 for innovations that address unmet pediatric needs

Washington D.C., April 05, 2022 (GLOBE NEWSWIRE) — Recognizing the continued gap in the development and commercialization of medical devices for children versus adults, the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), in collaboration with MedTech Innovator, is accepting applications through April 22, 2022, for its annual “Make Your Medical Device Pitch for Kids!” competition. Recognizing the wide range of unmet needs for diagnostic and therapeutic devices designed especially for children, this year’s competition is open to any innovation in medical technology that addresses a significant unmet need in pediatric medical care. ...  Read more

United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation

United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation

In subjects with PAH, transition from Tyvaso® to Tyvaso DPI™ demonstrated safety and tolerability with significant improvements in six-minute walk distance, device preference and satisfaction, and patient reported outcomes

Tyvaso DPI safety confirmed through 51 weeks of optional extension phase data with no study drug-related serious adverse events

FDA action on the New Drug Application for Tyvaso DPI is expected by May 2022

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–April 6, 2022–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the publication of additional clinical and long-term safety data from the BREEZE study evaluating Tyvaso DPI™ (treprostinil) in patients with pulmonary arterial hypertension (PAH) in the journal Pulmonary Circulation...  Read more